Elevance Health Inc. (ELV) Tops Q1 EPS by 16c, tops guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Elevance (ELV) PT Raised to $575 at RBC Capital
April 19, 2024 6:46 AM EDTRBC Capital analyst Ben Hendrix raised the price target on Elevance (NYSE: ELV) to $575.00 (from $574.00) while maintaining a Outperform rating.
The analyst comments "Elevance again outperforms against a difficult managed care backdrop, with utilization across the benefit businesses tracking in line with expectations.... More
Elevance (ELV) PT Raised to $605 at UBS
April 19, 2024 6:36 AM EDTUBS analyst AJ Rice raised the price target on Elevance (NYSE: ELV) to $605.00 (from $585.00) while maintaining a Buy rating.
The analyst comments "ELV provided a few more details around its recently announced CDR partnership, noting that the care delivery entity will start... More
Elevance (ELV) PT Raised to $600 at Wells Fargo
April 19, 2024 5:57 AM EDTWells Fargo analyst Stephen Baxter raised the price target on Elevance (NYSE: ELV) to $600.00 (from $557.00) while maintaining a Overweight rating.
The analyst comments "ELV's 1Q24 results were strong and earnings quality appears high. Story remains fairly clean from our perspective. Continued growth... More
Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
April 18, 2024 7:03 AM EDTShares of Elevance Health (NYSE: ELV) rose 3% after the health insurance provider topped earnings expectations for the fiscal Q1 and raised its outlook for the full fiscal 2024.
The companys first-quarter earnings per share (EPS) came in at $10.64, topping consensus estimates of $10.48. Revenue was... More
